Parisi Gray Wealth Management’s Ascendis Pharma A/S ASND Stock Holding History

Parisi Gray Wealth Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-167	Closed	-$22K	–	167
2021 Q2	$22K	Buy	+167	New	+$22.3K	0.01%	368
2019 Q2	–	Sell	-200	Closed	-$24K	–	141
2019 Q1	$24K	Hold	200	–	–	0.02%	291
2018 Q4	$12K	Hold	200	–	–	0.01%	360
2018 Q3	$13K	Hold	200	–	–	0.01%	370
2018 Q2	$14K	Hold	200	–	–	0.01%	367
2018 Q1	$12K	Hold	200	–	–	0.01%	402
2017 Q4	$8K	Buy	+200	New	+$7.27K	0.01%	480

Other funds holding ASND

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Parisi Gray Wealth Management's ASND Position: Q3 2021 in Review

Parisi Gray Wealth Management sold out of Ascendis Pharma A/S (ASND) in Q3 2021, closing a stake of 167 shares — an estimated $22K sold.

Parisi Gray Wealth Management first reported a position in ASND in Q4 2017 and held it in 7 quarters. The position peaked at $24K in Q1 2019. 166 funds tracked by Wall St. Rank hold ASND as of Q3 2021.

Parisi Gray Wealth Management reported no remaining Ascendis Pharma A/S position as of Q3 2021 after selling out during the quarter.
Parisi Gray Wealth Management sold 167 Ascendis Pharma A/S shares in Q3 2021, an estimated $22K.
Parisi Gray Wealth Management first reported a position in Ascendis Pharma A/S in Q4 2017 and held it in 7 quarters.
Parisi Gray Wealth Management's Ascendis Pharma A/S position peaked at $24K in Q1 2019.
166 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2021.

Based on Parisi Gray Wealth Management's 13F filing for Q3 2021, filed 16 Nov 2021.